Low burden of clinically relevant anaemiaand thrombocytopenia among adolescentsliving with HIV receiving tenofovir/lamivudineplus dolutegravir: the CIPHER-ADOLA studyin Cameroon
mai 6, 2026
Diagnostic Concordance of Two-andThree-GeneSARS-CoV-2Molecular Assays in Cameroon: Implicationsfor Efficient Pandemic Response in Low-andMiddle-IncomeCountries
mai 7, 2026
Par Ndié J., Noah J.P.Y.A., Ndongo F.A. et al.
Abstract
Background: The risk of HIV transmission during pregnancy remains a concern in Cameroon. Recent estimates suggest a national HIV prevalence of approximately 4.5%, increasing the likelihood of vertical transmission.
Objective: To estimate HIV seroprevalence and identify sociodemographic and obstetric determinants of HIV infection among pregnant women attending antenatal care in Cameroon.
Methods: A cross-sectional study was conducted from September 2022 to June 2023 among pregnant women aged 15 years and above in 324 health facilities across eight regions. Consecutive voluntary sampling was used until the site-specific sample size was reached. Facilities were purposively selected based on monthly ANC attendance >30. HIV screening followed the national algorithm. Multivariable Complementary Log-Log regression was used to identify factors associated with HIV infection, and adjusted prevalence ratios (aPRs) with 95% confidence intervals (CIs) were reported. Data were analysed using Excel and SPSS 27.
